Search
Close this search box.
×
Search
[custom_company_search_form]
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)

Stock Piper AI Index

Stock Piper AI Index

Subscribe
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)
Lithium
45.28
0.49%
Gold
2,667.60
0.53%
Copper
4.12
(0.9%)
Oil
69.68
0.19%
Bitcoin
97,615.48
3.46%
FTSE 100
8,076.71
(0.1%)
Nikkei 225
38,026.17
(0.85%)
Dow Jones
43,408.47
0.26%
Iron Ore
102.10
1.06%
USD/AUD
0.65
0.03%
Hang Seng
19,601.11
(0.23%)

Orthocell Ltd

OCC

ASX

Orthocell Limited (OCC) specialises in regenerative medicine, dedicated to enhancing mobility for patients through innovative products designed to repair a range of bone and soft tissue injuries. At the core of Orthocell's offerings is the CelGro platform, a series of collagen-based medical devices engineered to facilitate tissue reconstruction and promote healing across diverse applications in dental and orthopedic reconstructive procedures. Their focus on regenerative solutions underscores their commitment to advancing patient care and improving outcomes in medical interventions.

Latest Posts

Line Chart with Gradient
Price
$0.000
-0.015 (-2.4%)
At Close (AEST)
Related Companies
AMPLIA THERAPEUTICS LIMITED
$ATX
AVITA MEDICAL INC.
$AVH
IDT AUSTRALIA LIMITED
$IDT
NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD
$NSB
ACTINOGEN MEDICAL LIMITED
$ACW

Leave a Comment on OCC


Comments for OCC

    Latest Posts

    orthocell-asx-occ-receives-regulatory-approval-for-remplir-in-singapore-occ
    Health Care $OCC

    Orthocell (ASX: $OCC) receives regulatory approval for Remplir in singapore

    First major international approval for nerve repair product in strategic market

    October 8, 2024
    orthocell-asx-occ-expands-global-market-with-first-sales-of-striate-in-canada-occ
    Health Care $OCC

    Orthocell (ASX: $OCC) expands global market with first sales of Striate+™ in Canada

    BioHorizons records first sales of Striate+™ in Canada, accelerating market access into new large markets

    September 6, 2024
    orthocell-asx-occ-reports-record-quarterly-revenue-occ
    Health Care $OCC

    Orthocell (ASX: $OCC) reports record quarterly revenue

    Quarterly revenue up 30.4% year-on-year, strong balance sheet with $20.60 million cash at bank

    July 16, 2024
    orthocell-asx-occ-pauses-trading-pending-further-announcement-occ
    Health Care $OCC

    Orthocell (ASX: $OCC) pauses trading pending further announcement

    Trading temporarily paused pending additional news from company

    July 10, 2024
    orthocell-asx-occ-requests-trading-halt-for-striate-regulatory-approval-in-canada-occ
    Health Care $OCC

    Orthocell (ASX: $OCC) requests trading halt for Striate regulatory approval in Canada

    Company seeks trading halt pending announcement on Striate regulatory approval in Canada

    July 10, 2024
    orthocell-asx-occ-to-launch-third-revenue-generating-product-in-smrtgrafttm-for-tendon-repair-occ
    Health Care $OCC

    Orthocell (ASX: $OCC) to launch third revenue generating product in SmrtGraftTM for tendon repair

    Company submits TGA application for approval to commence sales of SmrtGraftTM in Australia, targeting tendon repair and regeneration market

    June 11, 2024
    orthocell-asx-occ-announces-outstanding-98-6-success-rate-from-dental-implant-study-occ
    Health Care $OCC

    Orthocell (ASX: $OCC) announces outstanding 98.6% success rate from dental implant study

    Results from Striate+™ dental implant study confirm Orthocell's product as optimal medical device for guided bone regeneration

    May 14, 2024
    orthocell-asx-occ-reports-19-revenue-growth-in-q3-fy24-occ
    Health Care $OCC

    Orthocell (ASX: $OCC) reports 19% revenue growth in Q3 FY24

    Successful completion of strategic placement and strengthening of Board

    April 8, 2024
    orthocell-asx-occ-requests-trading-halt-for-capital-raising-occ
    Health Care $OCC
    Orthocell (ASX: $OCC) requests trading halt for capital raisingOrthocell initiates trading halt on securities; anticipates major capital raising announcement

    October 24, 2024

    orthocell-asx-occ-achieves-record-revenue-growth-occ
    Health Care $OCC
    Orthocell (ASX: $OCC) achieves record revenue growthOrthocell reports $2.03 million revenue, secures regulatory approvals in Singapore and Canada

    October 17, 2024

    OCC

    $OCC

    Orthocell (ASX: $OCC) receives regulatory approval for Remplir in singapore

    First major international approval for nerve repair product in strategic market

    OCC

    $OCC

    Orthocell (ASX: $OCC) expands global market with first sales of Striate+™ in Canada

    BioHorizons records first sales of Striate+™ in Canada, accelerating market access into new large markets

    OCC

    $OCC

    Orthocell (ASX: $OCC) reports record quarterly revenue

    Quarterly revenue up 30.4% year-on-year, strong balance sheet with $20.60 million cash at bank

    OCC

    $OCC

    Orthocell (ASX: $OCC) pauses trading pending further announcement

    Trading temporarily paused pending additional news from company

    OCC

    $OCC

    Orthocell (ASX: $OCC) requests trading halt for Striate regulatory approval in Canada

    Company seeks trading halt pending announcement on Striate regulatory approval in Canada

    OCC

    $OCC

    Orthocell (ASX: $OCC) to launch third revenue generating product in SmrtGraftTM for tendon repair

    Company submits TGA application for approval to commence sales of SmrtGraftTM in Australia, targeting tendon repair and regeneration market

    OCC

    $OCC

    Orthocell (ASX: $OCC) announces outstanding 98.6% success rate from dental implant study

    Results from Striate+™ dental implant study confirm Orthocell's product as optimal medical device for guided bone regeneration

    OCC

    $OCC

    Orthocell (ASX: $OCC) reports 19% revenue growth in Q3 FY24

    Successful completion of strategic placement and strengthening of Board

    Related Companies
    OPTHEA LIMITED
    $OPT
    STARPHARMA HOLDINGS LIMITED
    $SPL
    PACIFIC EDGE LIMITED
    $PEB
    AFT PHARMACEUTICALS LIMITED
    $AFP
    BPH GLOBAL LTD
    $BP8DD

    ASX News, First
    & Fast.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    By clicking Subscribe, you agree to our Terms & Conditions
    © 2024 Stock Piper.
    All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support

    Socials

    Facebook
    Twitter
    LinkedIn
    © 2024 Stock Piper. All rights reserved

    Blog

    Healthcare
    Materials
    Real Estate
    Consumer Staples
    Consumer Discretionary Brief
    Utilities

    Company

    About us
    Terms of use
    Privacy Policy

    Support

    Contact Support
    © 2024 Stock Piper. All rights reserved
    Social Media Auto Publish Powered By : XYZScripts.com
    Stock Piper AI Index
    Subscribe
    Join FREE Newsletter

    Stock Piper AI Index Coming Soon!

    Join our Newsletter to gain exclusive insight and be notified once we are live.

    By clicking Subscribe, you agree to our Terms & Conditions

    ASX News, First And Fast.

    Get all the latest market updates straight to your inbox.

    By clicking Subscribe, you agree to our Terms & Conditions